Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Social Determinants of Health, the developing brain, and risk and resilience for psychopathology
    Published on 2025-07-16
    1 year ago
  • Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study
    Published on 2025-07-15
    1 year ago
  • M6A RNA epitranscriptome dynamics linked to major depressive disorder and suicide risk
    Published on 2025-07-10
    1 year ago
  • Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum
    Published on 2025-07-10
    1 year ago
  • Microglia as critical mediators linking perinatal immune stress to mental health trajectories
    Published on 2025-07-09
    1 year ago
  • A biological blind spot in addiction research: hormonal contraceptives and adolescent reward seeking
    Published on 2025-07-09
    1 year ago
  • Developmental sterol biosynthesis inhibition: are prescription medications as safe as we think?
    Published on 2025-07-08
    1 year ago
« Previous 1 … 47 48 49 50 51 … 143 Next »
Journal of Psychopharmacology
  • Effects of stress-related neuromodulators on amygdala and hippocampus resting state functional connectivity
    Published on 2024-06-21
    2 years ago
  • Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study
    Published on 2024-06-18
    2 years ago
  • Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
    Published on 2024-06-18
    2 years ago
  • Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
    Published on 2024-06-15
    2 years ago
  • The pseudoscience of lithium and suicide: Reanalysis of a misleading meta-analysis
    Published on 2024-06-12
    2 years ago
  • Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
    Published on 2024-06-12
    2 years ago
  • Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities
    Published on 2024-06-10
    2 years ago
« Previous 1 … 47 48 49 50 51 … 150 Next »
European Neuropsychopharmacology
  • Sex representation in mental health research
    Published on 2024-04-24
    2 years ago
  • Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
    Published on 2024-04-24
    2 years ago
  • Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
    Published on 2024-04-21
    2 years ago
  • Pre-existing chronic physical morbidity and excess mortality in people with bipolar disorder: A population-based cohort study in 2008–2018
    Published on 2024-04-21
    2 years ago
  • The role of anxiety and insomnia in the relationship between COVID-19 perseverative cognition and depression: Parallel and serial mediation analyses
    Published on 2024-04-21
    2 years ago
  • Rare variants and clozapine: Reply
    Published on 2024-04-21
    2 years ago
  • Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic
    Published on 2024-04-21
    2 years ago
« Previous 1 … 47 48 49 50 51 … 168 Next »

   Pharma Pub